[Home ] [Archive]    
:: year 14, Issue 56 (9-2022) ::
3 2022, 14(56): 8-12 Back to browse issues page
Serum biomarkers for assessing glycemic control in diabetes mellitus
Mohammad Ali Takhshid1, Rita Arabsolghar1
1- Medical Laboratory Sciences Department, Paramedical school, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract:   (271 Views)
Clinical evidence has revealed the association between complications Diabetes Mellitus (DM) and serum glycemic control. Thus, evaluation of the glycemic control status is crucial in the management of DM. Hemoglobin A1c (HbA1c) is the most common method for monitoring serum glycemic control. However, several confounding factors including red blood cell lifespan and hemoglobinopathies can affect HbA1c levels. Fructosamine, glycated albumin, 1,5-anhydroglucitol are serum markers of glycemic controls that can be used in such conditions. The present review article aims to explore the analytical and clinical aspects of these biomarkers.
Article number: 1
Keywords: Diabetes Mellitus, Glycemic Control, Fructosamine, Glycated Albumin, 1, 5-anhydroglucitol
Full-Text [PDF 266 kb]   (99 Downloads)    
Type of Study: Review | Subject: بیوشیمی
Received: 2022/09/18 | Accepted: 2022/09/19 | Published: 2022/09/19
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Takhshid M A, Arabsolghar R. Serum biomarkers for assessing glycemic control in diabetes mellitus. 3 2022; 14 (56) :8-12
URL: http://labdiagnosis.ir/article-1-506-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
year 14, Issue 56 (9-2022) Back to browse issues page
Laboratory & Diagnosis
Persian site map - English site map - Created in 0.05 seconds with 29 queries by YEKTAWEB 4513